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3What Are Models?
 Mathematical models use equations to represent disease 
transmission in the real world and can provide insights into 
outbreak emergence, spread and control
 Using advanced methods for data analysis, optimization, and high 
performance computing, models can translate the basic science 
of infectious diseases into practical public health guidance
 Models can predict where and when events will occur, allowing 
better outbreak preparedness and response
4The Questions 
Where are infectious diseases spreading today?
Where will they be spreading tomorrow?
 How can we use limited resources to minimize death 
and illness during outbreaks?
5Where Are Outbreaks Today?
 In initial stages of an outbreak, 
data are sparse and biased
 Novel modeling strategies glean 
useful information from diverse 
data sources
Scarpino SV et al. Clinical Infectious Diseases. 2015 Jan
Characterization of Ebola 
transmission based on viral 
sequence data and Facebook 
case reports
6Where Are Outbreaks Today?
 Optimizing surveillance systems
 Models learn from past outbreaks to improve 
data collection, situational awareness and 
outbreak prediction
Scarpino SV, Dimitrov NB, Meyers LA. PLoS Computational Biology. 2012 Apr
http://www.aphl.org/aphlprograms/infectious/influenza/Pages/Influenza-Virologic-Right-Size-Sample-Size-Calculators.aspx
Models used to determine where 
and when to collect influenza 
specimens to efficiently detect 
emerging viruses and select 
strains for inclusion in next 
season’s vaccine
7Where Are Outbreaks Today?
DTRA: Defense Threat Reduction Agency
BSVE: Biosurveillance Ecosystem 
Biosurveillance Ecosystem Surveillance App
8Where Will They Be Tomorrow?
CDC’s Predict the Influenza Season Contest
Early Season Flu Forecasted 
Actual Flu Trajectory
9Forecast to Support Decision Making
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Focus Models on Key Quantities 
Early Season Flu Forecasted 
Actual Flu Trajectory
Forecasted Point
Actual Data 
CDC’s Predict the Influenza Season Contest
Onset
Peak
End
11
How Can We Use Models to 
Optimally Mitigate Outbreaks?
 Clearly articulate goals
 Deepen intuition 
 Transmission dynamics
 Impacts of interventions
 Biases of surveillance data
 Improve preparedness
 Inform “quantitative” decisions 
 Optimize stockpiling and 
allocation of medical 
countermeasures
http://flu.tacc.utexas.edu
Singh B, Huang HC, Morton D, et al.  Emerging Infectious Diseases. 2015 Feb
12
How Can We Optimally Mitigate Outbreaks?
Bellan SE, Pulliam JR, Dushoff J, Meyers LA. Lancet. 2014 Oct
Gutfraind A, Meyers LA. J Infect Dis. 2015 Apr 
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Opportunities
 Transformative moment for modeling
 Upsurge in government appreciation and investment
 Widening collaborations between decision-makers and modelers
 Increase in model-driven policies for outbreak prevention 
and control
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Challenges
 New opportunities bring “new” (and old) challenges
 Access to reliable historical data and real-time data
 Model outputs only as good as their inputs
 Legitimate concerns about privacy and safety 
 Urgent need for best practices and shared resources
 Sustainability of modeling tools
 Rapidly changing technological infrastructure and data resources
 User training and support
15
Martin I. Meltzer, PhD
Lead, Health Economics and Modeling Unit
Division of Preparedness and Emerging Infections
National Center for Emerging and Zoonotic Infectious Diseases
What Do Policy Makers Expect from Modelers 
during a Response?
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Initial Questions from Leadership 
That Modeling Helps Inform 
 Forecasting: How many cases will there be at any 
point and in total (with frequent updates)?
 What would be the impact of interventions?
 When will the epidemic end?
 With an intervention
 Without an intervention
17
Key Questions During The 
2009 H1N1 Influenza Pandemic
 Spring
 How virulent and transmissible is 2009 H1N1?
 School closures — when and where for best impact?
 Fall and Winter
 When would the fall wave begin?
 When would the fall wave peak?
 How much benefit will vaccination deliver?
 Would age-specific attack rates change?
 Would there be a winter (third) wave? 
18
Archive: Updates of CDC estimates at: http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm
Shrestha SS, Swerdlow DL, Borse RH, et al. Clin Infect Dis. 2011 Jan 
2009 H1N1 Influenza Burden:
Near Real-time Estimates
61 million  cases                         
(range: 43 million to 89 million) 
• 274,000 hospitalizations
(range: 195,000 to 403,000)
• 12,470 deaths
(range: 8,870 to 18,300)
19
Yes, There Really Was a Pandemic:
2009 pH1N1 to Seasonal Influenza 
Shrestha SS, Swerdlow DL, Borse RH, et al. Clin Infect Dis. 2011 Jan 
Age 
(years)
Numbers per 100,000
Deaths Hospitalizations
Median Average Median Average
pH1N1 1990 to 1999 pH1N1 1979 to 2001
0–17 1.7 0.2 117.4 15.8
18–64 5.0 0.4 83.8 20.8
≥65 4.2 22.1 70.1 282.0
All 4.1 3.1 90.2 52.4
20
CDC Emergency Operations Center
Photo by Spencer Lowell for TIME magazine 
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Modeling Projections of Cases With 
and Without Interventions
Corrected for potential underreporting by multiplying reported cases by a factor of 2.5 
MMWR Surveill Summ 2014;63 Suppl 3
Liberia: August 2014 Estimates 
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Response Time Matters –
Cases Could Triple For Every Month of Inaction
Data are not corrected for potential underreporting
MMWR Surveill Summ 2014;63 Suppl 3
Liberia Case Estimates, Based on August 2014 Data
2014                                                       2015
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Estimates Compared to Actual Reported Cases
with and without Correction for Underreporting
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Frieden TR, Damon IK.  Emerg Infect Dis. 2015 Nov
Liberia Estimates, Based on August 2014 Data
Blue vertical 
bar represents 
correction for 
underreporting, 
by factor of 2.5.
Corrected for 
Underreporting
Uncorrected
Reported cases, 
~8,500 through mid-January, 
were within 23% of model estimates.
1/20
-
24
Rainisch G, Shankar M, Wellman M, et al. Emerg Infect Dis. 2015 Mar
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Modeling’s Major Contributions During 
Emergency Response
 Estimation of possible size of outbreak before large 
amounts of data are available 
 Assessment of impact of interventions
 Identification of key data needs
 Value of what is known
 Value of what is not known
 Prioritize data collection efforts
26
Modeling’s Major Contributions During 
Emergency Response
 Simple modeling tools that can be widely disseminated
SurvCost – http://www.cdc.gov/idsr/survcost.htm
to aid public health officials to estimate the cost of Integrated Disease Surveillance and 
Response (IDSR) systems
FluWorkLoss – http://www.cdc.gov/flu/pandemic-resources/tools/index.htm
to estimate the potential number of days lost from work due to an influenza pandemic
MedCon – http://emergency.cdc.gov/planning/medcon/
to estimate the baseline medical care requirements of a displaced population following a disaster
EbolaResponse – http://stacks.cdc.gov/view/cdc/24900
to estimate the number of Ebola cases in a community, and assess the potential impact of proposed 
interventions using a spreadsheet-based model 
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What Is Needed For Modeling To Be Of Use 
To Leadership In A Response
 Accessible to leadership
 Best if modeling and modelers are on site iterations
 Need for lots of “back and forth” to clarify data and the question
 Publication NOT the main goal
 Fast and frequent updates
 Available fast enough to help guide policy decisions
 Can be rapidly and easily updated when situation changes or 
more data are available
 Simple models
 Has to be able to be easily conveyed to decision and policy makers
 Spreadsheets or equivalent — post or make widely available
28
Application of Modeling and 
Forecasting for Preventing Influenza
Daniel B. Jernigan, MD, MPH
Director, Influenza Division
National Center for Immunization and Respiratory Diseases
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Organizing Framework for Use of Risk Assessment 
and Modeling Tools Before and After Emergence
Holloway R, Rasmussen S, Zaza S, et al.  MMWR Recomm Rep. 2014 Sep
30
Organizing Framework for Use of Risk Assessment 
and Modeling Tools Before and After Emergence
Virus Fitness 
Forecasting
Influenza Risk 
Assessment Tool
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Burden and 
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Organizing Framework for Use of Risk Assessment 
and Modeling Tools Before and After Emergence
Virus Fitness 
Forecasting
Influenza Risk 
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Forecasting
Burden and 
Impact 
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2014–152013–142012–132011–12
Estimated Hospitalizations
Influenza Surveillance 2011–2015
Reed C, Chaves SS, Kirley P, et al. PLoS One, 2015 Mar 
Unpublished CDC data for 2013-15
US Influenza Virologic Surveillance. www.cdc.gov/flu/weekly/overview.htm
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Burden, Burden Averted and Modeling
 Burden of influenza
 Hospitalization data and other inputs used to estimate 
 Total cases
 Total office visits 
 Hospitalizations 
 Deaths
 Burden averted through vaccines and antivirals
 Various inputs used to estimate number of cases, visits, 
hospitalizations and deaths averted through use of vaccine 
and antivirals
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Estimation and Impact Modeling
 Estimation of cases occurring due to 
novel influenza
 Determine total cases due to an emerging flu virus, e.g., H3N2v
 Impact estimation of different mitigation strategies
 Monovalent vaccine production in emergency
 Emergency use of antivirals at alternative care sites
35
Pandemic Severity Assessment Framework
 Available data 
evaluated for 
transmissibility 
and severity
 Scores are 
compared to 
past seasons 
and pandemics 
for historical 
grounding
Reed C, Biggerstaff M, Finelli L, et al. Emerg Infect Dis. 2013 Jan
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Influenza Risk Assessment Tool
Virus Fitness 
Forecasting
Influenza Risk 
Assessment Tool
Disease 
Forecasting
Burden and 
Impact 
Assessment 
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1. Genomic variation 
2. Receptor binding
3. Transmission in laboratory animals
4. Antivirals and treatment options
5. Existing population immunity
6. Disease severity and pathogenesis
7. Antigenic relationship to vaccine candidates
8. Global geographic distribution
9. Infection in animals, human risk of infection
10. Human infections and transmission
Ten Elements Evaluated in 
Influenza Risk Assessment Tool (IRAT)
Virus
Population
Ecology
IRAT: Influenza Risk Assessment Tool. http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm 
Trock SC, Burke SA, Cox NJ. Avian Dis. 2012 Dec
38
CDC Influenza Risk Assessment of 
Emerging Novel Influenza Viruses
IRAT: Influenza Risk Assessment Tool. http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm
Trock S, Burke S.  CDC Unpublished Data for H5NX Assessment
Trock S, Burke S, Cox N. Avian Dis. 2012 Dec 
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conducts risk 
assessments on 
emerging novel 
influenza viruses 
 Assess risk 
of emergence
 Assess impact, 
if emerges
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CDC Influenza Risk Assessment Tool (IRAT)
IRAT: Influenza Risk Assessment Tool. http://www.cdc.gov/flu/pandemic-resources/tools/risk-assessment.htm
 IRAT informs leadership regarding
 Readiness toolkit development (e.g., lab reagents)
 Vaccine and antiviral development, trials, and stockpiles
 Changes to diagnostics
 Changes to response posture
 Medical countermeasures, deployment
40
Disease Forecasting
Virus Fitness 
Forecasting
Influenza Risk 
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Disease 
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Forecasts for the Onset and Peak of the 
2015–2016 Influenza Season
 Ten academic partners receive standard weekly CDC data inputs and 
provide their best predictions for onset, peak, and other key estimates
 CDC serves as model broker to assure
 Accurate and available data via web portal for participants
 Collaboration and comparison of outputs
 Ensemble models may provide best estimates
Biggerstaff, Reed, and Influenza Division Applied Research and Modeling Team
42
Dynamic Modeling
Models of Infectious Disease Agent 
Study (MIDAS)
 Academic and government collaboration
 Develop complex mathematical models to test 
impact of:
 Different influenza emergence scenarios
 Variations and timing of interventions
 Models incorporate multiple inputs and 
assumptions
 Other groups developing dynamic 
influenza models 
 DHS, DoD, BARDA, LANL, ORNL, WHO
DHS: Department of Homeland Security                                         ARDA: Biomedical Advanced Research & Development Authority
DoD: Department of Defense                                                          LANL:  Los Alamos National Laboratory                                                                                            
ORNL:Oak Ridge National Laboratory https://www.nigms.nih.gov/research/specificareas/MIDAS/Pages/default.aspx
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Virus Fitness Forecasting
Virus Fitness 
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Influenza Risk 
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Disease 
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Possibilities for Real-Time Genomic
and Antigenic Virus Fitness Forecasting?
http://www.nextflu.org/H3N2/1y/
 CDC, WHO, and collaborators 
work to develop models 
to combine:
 Whole genome, next-generation, 
sequencing data
 Antigenic data describing host 
responses to flu virus proteins
 Geotemporal and epidemiologic data 
from surveillance
 Goal is to identify most likely 
viruses to predominate and  
improve selection of candidate 
vaccine viruses
45
Conclusions
 Practical use of historic and historical data can help 
estimate impact of emerging influenza severity
Modeling of epidemiologic and laboratory findings can 
be used to estimate likelihood of novel, animal-origin 
influenza emergence and severity 
 Influenza disease forecasting through ensemble 
modeling efforts may help disease control efforts
 Use of epidemiologic, genomic, and antigenic modeling 
forecasts may help select best vaccine virus candidates
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Models as Decision Support Tools:
Explanation, Foresight, Prediction
Richard J. Hatchett, MD
Chief Medical Officer and Deputy Director
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
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Models as Tools for Decision Making
“Prediction implies an ability to 
discern a particular turn of events.  
Foresight identifies variables and 
a range of alternatives that might 
better prepare for the future.”
– Richard Danzig
Models provide an input to 
decision making by 
 Explaining phenomena
 Providing foresight
 Making predictions
Richard Danzig, Driving in the Dark: Ten Propositions about Prediction and National Security Center for a New American Security, 2011
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Decision Makers Need to Recognize
Limitations of Models
Models are a tool to help frame decisions
Models are highly stylized representations of the 
world and are typically fit to specific purpose 
 Whatever purpose decision makers defined 
 Decision makers must be careful not to misuse them
 Limit conclusions to domains that the model was designed 
to address
 Models should not be used in isolation
49
NPIs: Nonpharmaceutical interventions
Halloran ME, Ferguson NM, Eubank S, et al. Proc Natl Acad Sci U S A. 2008 Mar 
Explanatory Models
Percent infected before measures started 
 Models can provide a means for 
understanding observed outcomes
 Modelers looked at the impact of 
the timing and use of NPIs 
(e.g., social distancing measures, 
including closing schools and 
banning large gatherings) on 
overall attack rates
 Efficacy of such measures was 
substantially enhanced if 
they were introduced early in 
an epidemic
50
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Interventions (NPIs) in 1918 Epidemic 
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Examples of Ways In Which
Models Provide Foresight
 Facilitate analysis and understanding of 
sparse datasets  
 Early readouts during 2009 H1N1 response
 Enhance intuition by allowing exploration of 
what-ifs
 Efficacy of isolation and quarantine in SARS, smallpox, 
and influenza
 Establish risk boundaries 
 Risk of sexual transmission of Ebola
53
Risk of Sexual Transmission of Ebola
Eggo RM, Watson CH, Camacho A, et al. Euro Surveill. 2015 Dec 
 Ebola virus can persist in 
semen for months, producing a 
sustained risk of transmission
 Eggo, et al., combined recent 
data on viral RNA persistence 
with weekly disease incidence 
to estimate the current number 
of semen-positive men in 
affected West African countries
 The risk of sexual transmission 
has declined significantly but 
will persist into 2016
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Risk of Sexual Transmission of Ebola
 Ebola virus can persist in 
semen for months, producing a 
sustained risk of transmission
 Eggo, et al., combined recent 
data on viral RNA persistence 
with weekly disease incidence 
to estimate the current number 
of semen-positive men in 
affected West African countries
 The risk of sexual transmission 
has declined significantly but 
will persist into 2016
Eggo RM, Watson CH, Camacho A, et al. Euro Surveill. 2015 Dec 
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Repeated Comparison of Predict vs. Actual 
Outcomes Has Improved Accuracy of Models 
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National Centers for Environmental Prediction at NOAA
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Combining Multiple Predictive Models May 
Provide More Informative Forecasts
 There is usually no “best” predictive model
 For decision making,
combining multiple 
models into a single 
risk forecast that 
captures model 
uncertainty may 
be preferable
Multiple pathways modeled for Hurricane Ike
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Combining Multiple Predictive Models 
Shrinks Cone of Error
 As modeling techniques improve, the cone of 
error for aggregate 
models shrinks
 As the time horizon 
is extended, the cone 
of error widens and 
uncertainty increases
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Figure based on a regression transmission model developed by Jason Asher, ASPR/BARDA (CTR)
 Epidemic modelers 
are developing 
techniques that help 
emerging data to 
“speak for itself”
 As data accumulate, 
the accuracy of the 
predictions improves
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The Prosocial Function Of Modeling: 
Conduit for Communication
With thanks to Steve Bankes
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